Literature DB >> 18452184

RAGE recycles at the plasma membrane in S100B secretory vesicles and promotes Schwann cells morphological changes.

Lorena Perrone1, Gianfranco Peluso, Mariarosa Ab Melone.   

Abstract

RAGE is a multiligand receptor of the immunoglobulin superfamily involved in regeneration of injured peripheral nerve and cell motility. RAGE is implicated in the development of various chronic diseases, such as neurodegenerative disorders, inflammatory responses, and diabetic complications. The correlation between RAGE endocytic trafficking and RAGE function is still uninvestigated. S100B is one of the ligands of RAGE. The molecular mechanisms responsible of S100B translocation in exocytic vesicles are still poorly investigated. In the present study we elucidate the role of RAGE endocytic trafficking in promoting S100B secretion in Schwann cells. Here we show that RAGE-induced secretion of S100B requires phosphorylated caveolin1-dependent endocytosis of RAGE. Endocytosis of RAGE in response to ligand binding promotes the fusion of endosomes with S100B-positive secretory vesicles. Src promotes the fusion of endosomes with S100B-secretory vesicles. Inhibition of src induces RAGE degradation. RAGE-mediated src activation induces cav1 phosphorylation and relocalization in the perinuclear compartment. RAGE signaling and recycling are required for S100-induced Schwann cells morphological changes and are inhibited by high-glucose, suggesting a possible link between diabetes and peripheral nerve injury. Indeed, high glucose inhibits RAGE-mediated src activation. Src inhibition blocks RAGE recycling, S100B secretion, and morphological changes. In summary, we identified a novel pathway of vesicular trafficking required for the amplification of RAGE signaling and cytoskeleton dynamics that is potentially involved in the regeneration of injured peripheral nerve. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452184     DOI: 10.1002/jcp.21474

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  27 in total

1.  The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration.

Authors:  S M Hearst; L R Walker; Q Shao; M Lopez; D Raucher; P J S Vig
Journal:  Neuroscience       Date:  2011-09-17       Impact factor: 3.590

Review 2.  The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders.

Authors:  W K Jo; A C K Law; S K Chung
Journal:  Mol Psychiatry       Date:  2014-01-07       Impact factor: 15.992

3.  Verapamil Inhibits Ser202/Thr205 Phosphorylation of Tau by Blocking TXNIP/ROS/p38 MAPK Pathway.

Authors:  Mariarosa Anna Beatrice Melone; Clemente Dato; Simona Paladino; Cinzia Coppola; Claudia Trebini; Maria Teresa Giordana; Lorena Perrone
Journal:  Pharm Res       Date:  2018-02-05       Impact factor: 4.200

4.  Receptor for Advanced Glycation End-Products (RAGE) Blockade Do Damage to Neuronal Survival via Disrupting Wnt/β-Catenin Signaling in Spinal Cord Injury.

Authors:  Hongyu Wang; Ziming Zhao; Chang Liu; Zhanpeng Guo; Yajiang Yuan; Haoshen Zhao; Zipeng Zhou; Xifan Mei
Journal:  Neurochem Res       Date:  2018-05-22       Impact factor: 3.996

5.  Gpr126/Adgrg6 contributes to the terminal Schwann cell response at the neuromuscular junction following peripheral nerve injury.

Authors:  Albina Jablonka-Shariff; Chuieng-Yi Lu; Katherine Campbell; Kelly R Monk; Alison K Snyder-Warwick
Journal:  Glia       Date:  2019-12-24       Impact factor: 7.452

6.  The receptor for advanced glycation end products mediates lung endothelial activation by RBCs.

Authors:  Nilam S Mangalmurti; Jessica L Friedman; Liang-Chuan Wang; Donna Stolz; Geetha Muthukumaran; Don L Siegel; Ann Marie Schmidt; Janet S Lee; Steven M Albelda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-12-28       Impact factor: 5.464

7.  RAGE interacts with the necroptotic protein RIPK3 and mediates transfusion-induced danger signal release.

Authors:  Hilary Faust; Lk Metthew Lam; Meghan J Hotz; Danielle Qing; Nilam S Mangalmurti
Journal:  Vox Sang       Date:  2020-07-07       Impact factor: 2.144

Review 8.  Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma.

Authors:  Mihaela Aldea; Ioan Alexandru Florian; Gabriel Kacso; Lucian Craciun; Sanda Boca; Olga Soritau; Ioan Stefan Florian
Journal:  Pharm Res       Date:  2016-05-26       Impact factor: 4.200

9.  S100B protein in tissue development, repair and regeneration.

Authors:  Guglielmo Sorci; Francesca Riuzzi; Cataldo Arcuri; Claudia Tubaro; Roberta Bianchi; Ileana Giambanco; Rosario Donato
Journal:  World J Biol Chem       Date:  2013-02-26

10.  The S100B/RAGE Axis in Alzheimer's Disease.

Authors:  Estelle Leclerc; Emmanuel Sturchler; Stefan W Vetter
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.